BioSpace News Archive

Arrigo Medical Devices, a leading provider of high-quality medical supplies and devices, is thrilled to announce its participation at Medical Design & Manufacturing West 2024, North America’s premier medtech conference.

Terns Pharmaceuticals, Inc. announced that it has granted as of February 1, 2024 an equity inducement award to a new employee under the terms of the 2022 Employment Inducement Award Plan, as amended.

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to 24 new employees.

Applied DNA Sciences, Inc. announced that it has closed its previously announced registered direct offering of its common stock priced at-the-market under Nasdaq rules with certain existing institutional investors for the sale of an aggregate of 5,644,061 of its shares of common stock at a purchase price of $0.609 per share.

Spyre Therapeutics, Inc. announced that Spyre’s independent Compensation Committee of the Board of Directors approved the grants of stock options to purchase an aggregate of 125,000 shares of common stock of Spyre to two non-executive employees as equity inducement awards under the Spyre Therapeutics, Inc. 2018 Equity Inducement Plan, as amended.

Hemogenyx Pharmaceuticals plc is pleased to announce that a patent application entitledMethod of Eliminating Hematopoietic Stem Cells/Hematopoietic Progenitors In A Patient Using Bi-Specific Antibodieshas been allowed to be issued as a patent by the United States Patent and Trademark Office.

Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, announced its business update and year-end report for January to December 2023.

Nathaniel A. Dyment, PhD, was named the recipient of the 2024 Kappa Delta Young Investigator Award for his findings on biophysical and biochemical cues that direct the growth and development, homeostasis and repair of tendons and ligaments.

The 2024 Orthopaedic Research and Education Foundation Clinical Research Award was presented to Christopher H. Evans, PhD, Steven C. Ghivizzani, PhD, and Paul D. Robbins, PhD, for their research on local gene therapy for osteoarthritis.

Regeneron Pharmaceuticals, Inc. announced that the European Medicines Agency has accepted for review the Marketing Authorization Application for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma who have progressed after at least three prior therapies.